Apple Heart & Movement Study

Prevention Clinical Trial

Official title:

Apple Heart & Movement Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04198194
• Other study ID #: 2019P002257
• Status: Recruiting
• Start date: November 14, 2019
• Est. completion date: November 14, 2024

Study information

• Verified date: July 2021
• Source: Apple Inc.
• Contact: Research Studies Support Center
• Phone: 833-237-3881
• Email: AppleHeartandMovementStudy[@]bwh.harvard.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500000
• Est. completion date: November 14, 2024
• Est. primary completion date: November 14, 2024
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);

• Live in the United States of America;

• Have an iPhone;

• Have an Apple Watch (Series 1 or later) at the time of enrollment;

• Have the Apple Research app installed on your iPhone;

• Be comfortable communicating in written and spoken English;

• Not share your iCloud account, iPhone, or Apple Watch with anyone else;

• Be willing and able to provide informed consent to participate in the study.

Related Conditions & MeSH terms

• Prevention

Intervention

Diagnostic Test:
• Predictors of events
Apple Heart & Movement Study in Apple Research app

Locations

Country	Name	City	State
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Apple Inc.	American Heart Association

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants with Chronic Disease Events	Change in number of participants with incident cardiovascular disease events (including myocardial infarction, coronary revascularization, heart failure hospitalization, stroke/TIA hospitalization, atrial fibrillation, and atrial fibrillation hospitalization), fall events, and other hospitalizations, assessed by patient report.	quarterly (every 90 days) through study completion (up to 5 years)